238 related articles for article (PubMed ID: 28891030)
21. 64Cu- and 68Ga-labelled [Nle(14),Lys(40)(Ahx-NODAGA)NH2]-exendin-4 for pancreatic beta cell imaging in rats.
Mikkola K; Yim CB; Fagerholm V; Ishizu T; Elomaa VV; Rajander J; Jurttila J; Saanijoki T; Tolvanen T; Tirri M; Gourni E; Béhé M; Gotthardt M; Reubi JC; Mäcke H; Roivainen A; Solin O; Nuutila P
Mol Imaging Biol; 2014 Apr; 16(2):255-63. PubMed ID: 24101374
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of
Kimura H; Ogawa Y; Fujimoto H; Mukai E; Kawashima H; Arimitsu K; Toyoda K; Fujita N; Yagi Y; Hamamatsu K; Murakami T; Murakami A; Ono M; Nakamoto Y; Togashi K; Inagaki N; Saji H
Bioorg Med Chem; 2018 Jan; 26(2):463-469. PubMed ID: 29273416
[TBL] [Abstract][Full Text] [Related]
23. Strain Differences Determine the Suitability of Animal Models for Noninvasive In Vivo Beta Cell Mass Determination with Radiolabeled Exendin.
Willekens SM; Joosten L; Boerman OC; Balhuizen A; Eizirik DL; Gotthardt M; Brom M
Mol Imaging Biol; 2016 Oct; 18(5):705-14. PubMed ID: 26886298
[TBL] [Abstract][Full Text] [Related]
24. Glucagon-Like Peptide-1 Receptor PET/CT with 68Ga-NOTA-Exendin-4 for Detecting Localized Insulinoma: A Prospective Cohort Study.
Luo Y; Pan Q; Yao S; Yu M; Wu W; Xue H; Kiesewetter DO; Zhu Z; Li F; Zhao Y; Chen X
J Nucl Med; 2016 May; 57(5):715-20. PubMed ID: 26795291
[TBL] [Abstract][Full Text] [Related]
25. Improving the Theranostic Potential of Exendin 4 by Reducing the Renal Radioactivity through Brush Border Membrane Enzyme-Mediated Degradation.
Zhang M; Jacobson O; Kiesewetter DO; Ma Y; Wang Z; Lang L; Tang L; Kang F; Deng H; Yang W; Niu G; Wang J; Chen X
Bioconjug Chem; 2019 Jun; 30(6):1745-1753. PubMed ID: 31181890
[TBL] [Abstract][Full Text] [Related]
26. Blocking of Glucagonlike Peptide-1 Receptors in the Exocrine Pancreas Improves Specificity for β-Cells in a Mouse Model of Type 1 Diabetes.
Khera E; Zhang L; Roberts S; Nessler I; Sandoval D; Reiner T; Thurber GM
J Nucl Med; 2019 Nov; 60(11):1635-1641. PubMed ID: 31076502
[TBL] [Abstract][Full Text] [Related]
27. 177Lu-DO3A-HSA-Z EGFR:1907: characterization as a potential radiopharmaceutical for radionuclide therapy of EGFR-expressing head and neck carcinomas.
Hoppmann S; Qi S; Miao Z; Liu H; Jiang H; Cutler CS; Bao A; Cheng Z
J Biol Inorg Chem; 2012 Jun; 17(5):709-18. PubMed ID: 22418921
[TBL] [Abstract][Full Text] [Related]
28. Preliminary evaluation of [18F]AlF-NOTA-MAL-Cys39-exendin-4 in insulinoma with PET.
Xu Q; Zhu C; Xu Y; Pan D; Liu P; Yang R; Wang L; Chen F; Sun X; Luo S; Yang M
J Drug Target; 2015; 23(9):813-20. PubMed ID: 25758750
[TBL] [Abstract][Full Text] [Related]
29. Development and evaluation of 18F-TTCO-Cys40-Exendin-4: a PET probe for imaging transplanted islets.
Wu Z; Liu S; Hassink M; Nair I; Park R; Li L; Todorov I; Fox JM; Li Z; Shively JE; Conti PS; Kandeel F
J Nucl Med; 2013 Feb; 54(2):244-51. PubMed ID: 23297075
[TBL] [Abstract][Full Text] [Related]
30. Development of novel radioiodinated exendin-4 derivatives targeting GLP-1 receptor for detection of β-cell mass.
Ogawa Y; Kimura H; Fujimoto H; Kawashima H; Toyoda K; Mukai E; Yagi Y; Ono M; Inagaki N; Saji H
Bioorg Med Chem; 2021 Dec; 52():116496. PubMed ID: 34808404
[TBL] [Abstract][Full Text] [Related]
31. Insulinoma imaging with glucagon-like peptide-1 receptor targeting probe (18)F-FBEM-Cys (39)-exendin-4.
Xu Y; Pan D; Xu Q; Zhu C; Wang L; Chen F; Yang R; Luo S; Yang M
J Cancer Res Clin Oncol; 2014 Sep; 140(9):1479-88. PubMed ID: 24838847
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and evaluation of optical and PET GLP-1 peptide analogues for GLP-1R imaging.
Behnam Azad B; Rota V; Yu L; McGirr R; St Amant AH; Lee TY; Dhanvantari S; Luyt LG
Mol Imaging; 2015; 14():. PubMed ID: 25762192
[TBL] [Abstract][Full Text] [Related]
33. Dosimetry of [(177)Lu]-DO3A-VS-Cys(40)-Exendin-4 - impact on the feasibility of insulinoma internal radiotherapy.
Velikyan I; Bulenga TN; Selvaraju R; Lubberink M; Espes D; Rosenström U; Eriksson O
Am J Nucl Med Mol Imaging; 2015; 5(2):109-26. PubMed ID: 25973333
[TBL] [Abstract][Full Text] [Related]
34. Activation of GLP-1 and gastrin signalling induces in vivo reprogramming of pancreatic exocrine cells into beta cells in mice.
Sasaki S; Miyatsuka T; Matsuoka TA; Takahara M; Yamamoto Y; Yasuda T; Kaneto H; Fujitani Y; German MS; Akiyama H; Watada H; Shimomura I
Diabetologia; 2015 Nov; 58(11):2582-91. PubMed ID: 26290048
[TBL] [Abstract][Full Text] [Related]
35. Islet-selectivity of G-protein coupled receptor ligands evaluated for PET imaging of pancreatic β-cell mass.
Cline GW; Zhao X; Jakowski AB; Soeller WC; Treadway JL
Biochem Biophys Res Commun; 2011 Sep; 412(3):413-8. PubMed ID: 21820405
[TBL] [Abstract][Full Text] [Related]
36. In vivo imaging of GLP-1R with a targeted bimodal PET/fluorescence imaging agent.
Brand C; Abdel-Atti D; Zhang Y; Carlin S; Clardy SM; Keliher EJ; Weber WA; Lewis JS; Reiner T
Bioconjug Chem; 2014 Jul; 25(7):1323-30. PubMed ID: 24856928
[TBL] [Abstract][Full Text] [Related]
37. Exendin-4 Derivatives with an Albumin-Binding Moiety Show Decreased Renal Retention and Improved GLP-1 Receptor Targeting.
Kaeppeli SAM; Jodal A; Gotthardt M; Schibli R; Béhé M
Mol Pharm; 2019 Sep; 16(9):3760-3769. PubMed ID: 31393738
[TBL] [Abstract][Full Text] [Related]
38. PET of glucagonlike peptide receptor upregulation after myocardial ischemia or reperfusion injury.
Gao H; Kiesewetter DO; Zhang X; Huang X; Guo N; Lang L; Hida N; Wang H; Wang H; Cao F; Niu G; Chen X
J Nucl Med; 2012 Dec; 53(12):1960-8. PubMed ID: 23139087
[TBL] [Abstract][Full Text] [Related]
39. Dosimetry of [(68)Ga]Ga-DO3A-VS-Cys(40)-Exendin-4 in rodents, pigs, non-human primates and human - repeated scanning in human is possible.
Selvaraju RK; Bulenga TN; Espes D; Lubberink M; Sörensen J; Eriksson B; Estrada S; Velikyan I; Eriksson O
Am J Nucl Med Mol Imaging; 2015; 5(3):259-69. PubMed ID: 26069859
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
